Last 12 months
Inside the activity.
3 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 3 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2023 Filed Feb 16, 2023 21:44 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Tax withholdingCommon Stock | 2,879 | $103.27 | $297,314.33 |
DisclosureSEC source: 0001127602-23-005575 · form4.xml · nonDerivative · entry 2 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,088 F2 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:44 UTC |
SCHMIDT TIMOTHY LSenior Vice President
|
Exercise / conversionCommon Stock | 7,869 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005575 · form4.xml · nonDerivative · entry 1 SCHMIDT TIMOTHY L · CIK 0001760181 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:47 UTC |
SULLIVAN ANDREW FExecutive Vice President
|
Exercise / conversion2020 Performance Share · Derivative | 20,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005581 · form4.xml · derivative · entry 6 SULLIVAN ANDREW F · CIK 0001795452 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,653 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:47 UTC |
SULLIVAN ANDREW FExecutive Vice President
|
Grant2023 Performance Shares · Derivative | 36,313 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005581 · form4.xml · derivative · entry 5 SULLIVAN ANDREW F · CIK 0001795452 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,313 Underlying: Common Stock · 36,313 shares Expires not disclosed F6 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F7 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2026 based on the Company's ROE performance relative to a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2023 through 2025 performance period. F7 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2026 based on the Company's ROE performance relative to a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2023 through 2025 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:47 UTC |
SULLIVAN ANDREW FExecutive Vice President
|
Grant2023 Restricted Stock Units · Derivative | 12,105 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005581 · form4.xml · derivative · entry 4 SULLIVAN ANDREW F · CIK 0001795452 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,105 Underlying: Common Stock · 12,105 shares Expires not disclosed F4 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F5 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning the last day of February 2024. F5 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning the last day of February 2024. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:47 UTC |
SULLIVAN ANDREW FExecutive Vice President
|
Tax withholdingCommon Stock | 7,143 | $103.27 | $737,657.61 |
DisclosureSEC source: 0001127602-23-005581 · form4.xml · nonDerivative · entry 2 SULLIVAN ANDREW F · CIK 0001795452 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,705 F2 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:47 UTC |
SULLIVAN ANDREW FExecutive Vice President
|
Exercise / conversionCommon Stock | 18,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005581 · form4.xml · nonDerivative · entry 1 SULLIVAN ANDREW F · CIK 0001795452 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:41 UTC |
Lowrey Charles FDirector · Chief Executive Officer · Chairman of the Board
|
Exercise / conversion2020 Performance Share · Derivative | 51,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005571 · form4.xml · derivative · entry 6 Lowrey Charles F · CIK 0001512629 · Director · Chief Executive Officer · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 51,946 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:41 UTC |
Lowrey Charles FDirector · Chief Executive Officer · Chairman of the Board
|
Grant2023 Performance Shares · Derivative | 94,413 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005571 · form4.xml · derivative · entry 5 Lowrey Charles F · CIK 0001512629 · Director · Chief Executive Officer · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,413 Underlying: Common Stock · 94,413 shares Expires not disclosed F6 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F7 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2026 based on the Company's ROE performance relative to a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2023 through 2025 performance period. F7 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2026 based on the Company's ROE performance relative to a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2023 through 2025 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:41 UTC |
Lowrey Charles FDirector · Chief Executive Officer · Chairman of the Board
|
Grant2023 Restricted Stock Units · Derivative | 31,471 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005571 · form4.xml · derivative · entry 4 Lowrey Charles F · CIK 0001512629 · Director · Chief Executive Officer · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,471 Underlying: Common Stock · 31,471 shares Expires not disclosed F4 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F5 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning the last day of February 2024. F5 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning the last day of February 2024. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:41 UTC |
Lowrey Charles FDirector · Chief Executive Officer · Chairman of the Board
|
Tax withholdingCommon Stock | 24,347 | $103.27 | $2,514,314.69 |
DisclosureSEC source: 0001127602-23-005571 · form4.xml · nonDerivative · entry 2 Lowrey Charles F · CIK 0001512629 · Director · Chief Executive Officer · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,617 F2 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:41 UTC |
Lowrey Charles FDirector · Chief Executive Officer · Chairman of the Board
|
Exercise / conversionCommon Stock | 46,648 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005571 · form4.xml · nonDerivative · entry 1 Lowrey Charles F · CIK 0001512629 · Director · Chief Executive Officer · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:38 UTC |
KAPPLER ANN MEVP and General Counsel
|
Exercise / conversion2020 Performance Share · Derivative | 3,756 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005567 · form4.xml · derivative · entry 6 KAPPLER ANN M · CIK 0001280546 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,756 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:38 UTC |
KAPPLER ANN MEVP and General Counsel
|
Grant2023 Performance Shares · Derivative | 19,972 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005567 · form4.xml · derivative · entry 5 KAPPLER ANN M · CIK 0001280546 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,972 Underlying: Common Stock · 19,972 shares Expires not disclosed F6 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F7 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2026 based on the Company's ROE performance relative to a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2023 through 2025 performance period. F7 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2026 based on the Company's ROE performance relative to a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2023 through 2025 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:38 UTC |
KAPPLER ANN MEVP and General Counsel
|
Grant2023 Restricted Stock Units · Derivative | 6,658 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005567 · form4.xml · derivative · entry 4 KAPPLER ANN M · CIK 0001280546 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,658 Underlying: Common Stock · 6,658 shares Expires not disclosed F4 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F5 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning the last day of February 2024. F5 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning the last day of February 2024. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:38 UTC |
KAPPLER ANN MEVP and General Counsel
|
Tax withholdingCommon Stock | 1,188 | $103.27 | $122,684.76 |
DisclosureSEC source: 0001127602-23-005567 · form4.xml · nonDerivative · entry 2 KAPPLER ANN M · CIK 0001280546 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,964 F2 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:38 UTC |
KAPPLER ANN MEVP and General Counsel
|
Exercise / conversionCommon Stock | 3,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005567 · form4.xml · nonDerivative · entry 1 KAPPLER ANN M · CIK 0001280546 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,152 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:36 UTC |
GOODMAN STACEYExecutive Vice President
|
Exercise / conversion2020 Performance Share · Derivative | 11,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005562 · form4.xml · derivative · entry 6 GOODMAN STACEY · CIK 0001661379 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,892 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:36 UTC |
GOODMAN STACEYExecutive Vice President
|
Grant2023 Performance Shares · Derivative | 19,972 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005562 · form4.xml · derivative · entry 5 GOODMAN STACEY · CIK 0001661379 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,972 Underlying: Common Stock · 19,972 shares Expires not disclosed F6 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F7 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2026 based on the Company's ROE performance relative to a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2023 through 2025 performance period. F7 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2026 based on the Company's ROE performance relative to a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2023 through 2025 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:36 UTC |
GOODMAN STACEYExecutive Vice President
|
Grant2023 Restricted Stock Units · Derivative | 6,658 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005562 · form4.xml · derivative · entry 4 GOODMAN STACEY · CIK 0001661379 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,658 Underlying: Common Stock · 6,658 shares Expires not disclosed F4 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F5 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning the last day of February 2024. F5 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning the last day of February 2024. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:36 UTC |
GOODMAN STACEYExecutive Vice President
|
Tax withholdingCommon Stock | 4,042 | $103.27 | $417,417.34 |
DisclosureSEC source: 0001127602-23-005562 · form4.xml · nonDerivative · entry 2 GOODMAN STACEY · CIK 0001661379 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,868 F2 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:36 UTC |
GOODMAN STACEYExecutive Vice President
|
Exercise / conversionCommon Stock | 10,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005562 · form4.xml · nonDerivative · entry 1 GOODMAN STACEY · CIK 0001661379 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:32 UTC |
FALZON ROBERTEVP and Vice Chairman
|
Exercise / conversion2020 Performance Share · Derivative | 41,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005552 · form4.xml · derivative · entry 7 FALZON ROBERT · CIK 0001256465 · EVP and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,306 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:32 UTC |
FALZON ROBERTEVP and Vice Chairman
|
Grant2023 Performance Shares · Derivative | 75,531 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005552 · form4.xml · derivative · entry 6 FALZON ROBERT · CIK 0001256465 · EVP and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,531 Underlying: Common Stock · 75,531 shares Expires not disclosed F5 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2026 based on the Company's ROE performance relative to a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2023 through 2025 performance period. F6 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2026 based on the Company's ROE performance relative to a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2023 through 2025 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:32 UTC |
FALZON ROBERTEVP and Vice Chairman
|
Grant2023 Restricted Stock Units · Derivative | 25,177 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005552 · form4.xml · derivative · entry 5 FALZON ROBERT · CIK 0001256465 · EVP and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,177 Underlying: Common Stock · 25,177 shares Expires not disclosed F3 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F4 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning the last day of February 2024. F4 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning the last day of February 2024. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:32 UTC |
FALZON ROBERTEVP and Vice Chairman
|
Tax withholdingCommon Stock | 17,525 | $103.27 | $1,809,806.75 |
DisclosureSEC source: 0001127602-23-005552 · form4.xml · nonDerivative · entry 2 FALZON ROBERT · CIK 0001256465 · EVP and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,243 F2 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:32 UTC |
FALZON ROBERTEVP and Vice Chairman
|
Exercise / conversionCommon Stock | 37,093 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005552 · form4.xml · nonDerivative · entry 1 FALZON ROBERT · CIK 0001256465 · EVP and Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,768 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:34 UTC |
Feeney CarolineExecutive Vice President
|
Exercise / conversion2020 Performance Share · Derivative | 8,762 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005558 · form4.xml · derivative · entry 6 Feeney Caroline · CIK 0001960842 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,762 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:34 UTC |
Feeney CarolineExecutive Vice President
|
Grant2023 Performance Shares · Derivative | 26,872 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005558 · form4.xml · derivative · entry 5 Feeney Caroline · CIK 0001960842 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,872 Underlying: Common Stock · 26,872 shares Expires not disclosed F5 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2026 based on the Company's ROE performance relative to a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2023 through 2025 performance period. F6 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2026 based on the Company's ROE performance relative to a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2023 through 2025 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:34 UTC |
Feeney CarolineExecutive Vice President
|
Grant2023 Restricted Stock Units · Derivative | 8,958 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005558 · form4.xml · derivative · entry 4 Feeney Caroline · CIK 0001960842 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,958 Underlying: Common Stock · 8,958 shares Expires not disclosed F3 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F4 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning the last day of February 2024. F4 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning the last day of February 2024. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:34 UTC |
Feeney CarolineExecutive Vice President
|
Tax withholdingCommon Stock | 2,870 | $103.27 | $296,384.90 |
DisclosureSEC source: 0001127602-23-005558 · form4.xml · nonDerivative · entry 2 Feeney Caroline · CIK 0001960842 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,125 F2 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:34 UTC |
Feeney CarolineExecutive Vice President
|
Exercise / conversionCommon Stock | 7,869 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005558 · form4.xml · nonDerivative · entry 1 Feeney Caroline · CIK 0001960842 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:30 UTC |
Axel RobertSVP and Controller
|
Exercise / conversion2020 Performance Share · Derivative | 4,381 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005547 · form4.xml · derivative · entry 6 Axel Robert · CIK 0001602678 · SVP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,381 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:30 UTC |
Axel RobertSVP and Controller
|
Grant2023 Performance Shares · Derivative | 4,745 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005547 · form4.xml · derivative · entry 5 Axel Robert · CIK 0001602678 · SVP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,745 Underlying: Common Stock · 4,745 shares Expires not disclosed F6 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F7 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2026 based on the Company's ROE performance relative to a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2023 through 2025 performance period. F7 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2026 based on the Company's ROE performance relative to a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2023 through 2025 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:30 UTC |
Axel RobertSVP and Controller
|
Grant2023 Restricted Stock Units · Derivative | 2,034 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005547 · form4.xml · derivative · entry 4 Axel Robert · CIK 0001602678 · SVP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,034 Underlying: Common Stock · 2,034 shares Expires not disclosed F4 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F5 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning the last day of February 2024. F5 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning the last day of February 2024. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:30 UTC |
Axel RobertSVP and Controller
|
Tax withholdingCommon Stock | 1,337 | $103.27 | $138,071.99 |
DisclosureSEC source: 0001127602-23-005547 · form4.xml · nonDerivative · entry 2 Axel Robert · CIK 0001602678 · SVP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,405 F2 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:30 UTC |
Axel RobertSVP and Controller
|
Exercise / conversionCommon Stock | 3,935 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005547 · form4.xml · nonDerivative · entry 1 Axel Robert · CIK 0001602678 · SVP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:26 UTC |
Alziari LucienExecutive Vice President
|
Exercise / conversion2020 Performance Share · Derivative | 14,082 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005542 · form4.xml · derivative · entry 5 Alziari Lucien · CIK 0001303114 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,082 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. F1 · derivative.exercise_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. F1 · derivative.expiration_date: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:26 UTC |
Alziari LucienExecutive Vice President
|
Grant2023 Performance Shares · Derivative | 19,972 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005542 · form4.xml · derivative · entry 4 Alziari Lucien · CIK 0001303114 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,972 Underlying: Common Stock · 19,972 shares Expires not disclosed F5 · derivative.exercise_price: The performance shares convert to common stock on a 1 to 1 basis. F6 · derivative.exercise_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2026 based on the Company's ROE performance relative to a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2023 through 2025 performance period. F6 · derivative.expiration_date: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2026 based on the Company's ROE performance relative to a performance peer group of companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2023 through 2025 performance period. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:26 UTC |
Alziari LucienExecutive Vice President
|
Grant2023 Restricted Stock Units · Derivative | 6,658 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005542 · form4.xml · derivative · entry 3 Alziari Lucien · CIK 0001303114 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,658 Underlying: Common Stock · 6,658 shares Expires not disclosed F3 · derivative.exercise_price: The Restricted Stock Units convert to common stock on a 1 to 1 basis. F4 · derivative.exercise_date: The Restricted Stock Units will vest 1/3 per year beginning the last day of February 2024. F4 · derivative.expiration_date: The Restricted Stock Units will vest 1/3 per year beginning the last day of February 2024. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:26 UTC |
Alziari LucienExecutive Vice President
|
Tax withholdingCommon Stock | 4,079 | $103.27 | $421,238.33 |
DisclosureSEC source: 0001127602-23-005542 · form4.xml · nonDerivative · entry 2 Alziari Lucien · CIK 0001303114 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,171 F2 · shares: Represents shares withheld for the payment of taxes. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:26 UTC |
Alziari LucienExecutive Vice President
|
Exercise / conversionCommon Stock | 12,646 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-005542 · form4.xml · nonDerivative · entry 1 Alziari Lucien · CIK 0001303114 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Compensation Committee determined the number of shares received based on the Company's return on equity ("ROE") performance relative to a pre-determined goal and relative to the ROE performance of certain life insurance peer companies for the 2020 through 2022 performance period. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 22:39 UTC |
SCOVANNER DOUGLAS ADirector
|
Exercise / conversionNotional Shares - Optional · Derivative | 1,693 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-001250 · form4.xml · derivative · entry 3 SCOVANNER DOUGLAS A · CIK 0001205002 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,256 Underlying: Common Stock · 1,693 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each notional share - optional represents a deferred stock unit and entitles the holder thereof with the right to receive one share of Issuer common stock or the cash value thereof under the Issuer's deferred compensation plan for non-employee directors. F1 · kind: Nondiscretionary transaction executed pursuant to the issuer's deferred compensation plan for non-employee directors. F3 · derivative.exercise_date: Such shares are payable in common stock or cash, at the election of the reporting person, with payment to begin, at the election of the reporting person provided that such date shall be at least two (2) years after the end of the plan year with respect to which such elective deferrals relate. The reporting person may transfer his investment in the notional shares - optional to an alternative investment account, subject to the terms of the Issuer's deferred compensation plan for non-employee directors. F3 · derivative.expiration_date: Such shares are payable in common stock or cash, at the election of the reporting person, with payment to begin, at the election of the reporting person provided that such date shall be at least two (2) years after the end of the plan year with respect to which such elective deferrals relate. The reporting person may transfer his investment in the notional shares - optional to an alternative investment account, subject to the terms of the Issuer's deferred compensation plan for non-employee directors. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 22:39 UTC |
SCOVANNER DOUGLAS ADirector
|
Exercise / conversionCommon Stock | 1,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-001250 · form4.xml · nonDerivative · entry 1 SCOVANNER DOUGLAS A · CIK 0001205002 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Nondiscretionary transaction executed pursuant to the issuer's deferred compensation plan for non-employee directors. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 22:31 UTC |
KRAPEK KARL JDirector
|
OtherNotional Shares - Optional · Derivative | 6,126 | $99.44 Strike: $0.00 | $609,169.44 |
DisclosureSEC source: 0001127602-23-001247 · form4.xml · derivative · entry 1 KRAPEK KARL J · CIK 0001238288 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,126 shares Expires not disclosed F1 · derivative.exercise_price: Each notional share - optional represents a deferred stock unit and entitles the holder thereof with the right to receive one share of Issuer common stock or the cash value thereof under the Issuer's deferred compensation plan for non-employee directors. F2 · derivative.exercise_date: Such shares are payable in common stock or cash, at the election of the reporting person, with payment to begin, at the election of the reporting person provided that such date shall be at least two (2) years after the end of the plan year with respect to which such elective deferrals relate. The reporting person may transfer his investment in the notional shares - optional to an alternative investment account, subject to the terms of the Issuer's deferred compensation plan for non-employee directors. F2 · derivative.expiration_date: Such shares are payable in common stock or cash, at the election of the reporting person, with payment to begin, at the election of the reporting person provided that such date shall be at least two (2) years after the end of the plan year with respect to which such elective deferrals relate. The reporting person may transfer his investment in the notional shares - optional to an alternative investment account, subject to the terms of the Issuer's deferred compensation plan for non-employee directors. Read SEC document |
| January 01, 2023 Filed Jan 3, 2023 21:36 UTC |
Baltimore Thomas J JrDirector
|
GrantNotional Shares - Optional · Derivative | 384 | $99.46 Strike: $0.00 | $38,192.64 |
DisclosureSEC source: 0001127602-23-000154 · form4.xml · derivative · entry 1 Baltimore Thomas J Jr · CIK 0001390946 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,607 Underlying: Common Stock · 384 shares Expires not disclosed F1 · derivative.exercise_price: Each notional share - optional represents a deferred stock unit and entitles the holder thereof with the right to receive one share of Issuer common stock or the cash value thereof under the Issuer's deferred compensation plan for non-employee directors. F2 · derivative.exercise_date: Such shares are payable in common stock or cash, at the election of the reporting person, with payment to begin, at the election of the reporting person provided that such date shall be at least two (2) years after the end of the plan year with respect to which such elective deferrals relate. The reporting person may transfer his investment in the notional shares - optional to an alternative investment account, subject to the terms of the Issuer's deferred compensation plan for non-employee directors. F2 · derivative.expiration_date: Such shares are payable in common stock or cash, at the election of the reporting person, with payment to begin, at the election of the reporting person provided that such date shall be at least two (2) years after the end of the plan year with respect to which such elective deferrals relate. The reporting person may transfer his investment in the notional shares - optional to an alternative investment account, subject to the terms of the Issuer's deferred compensation plan for non-employee directors. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:18 UTC |
Sleyster ScottExecutive Vice President
|
GrantDeferred Compensation Shares · Derivative | 200 | $99.75 Strike: $0.00 | $19,950.00 |
DisclosureSEC source: 0001127602-22-027835 · form4.xml · derivative · entry 1 Sleyster Scott · CIK 0001555872 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,377 Underlying: Common Stock · 200 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Compensation Shares are based on unitized accounting and convert to common stock on a 1 to 1 basis. F2 · derivative.exercise_date: Deferred Compensation Shares are deemed immediately exercisable and are payable in cash at a date selected by the participant. F2 · derivative.expiration_date: Deferred Compensation Shares are deemed immediately exercisable and are payable in cash at a date selected by the participant. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:14 UTC |
SULLIVAN ANDREW FExecutive Vice President
|
GrantDeferred Compensation Shares · Derivative | 62 | $99.75 Strike: $0.00 | $6,184.50 |
DisclosureSEC source: 0001127602-22-027832 · form4.xml · derivative · entry 1 SULLIVAN ANDREW F · CIK 0001795452 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,372 Underlying: Common Stock · 62 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Compensation Shares are based on unitized accounting and convert to common stock on a 1 to 1 basis. F2 · derivative.exercise_date: Deferred Compensation Shares are deemed immediately exercisable and are payable in cash at a date selected by the participant. F2 · derivative.expiration_date: Deferred Compensation Shares are deemed immediately exercisable and are payable in cash at a date selected by the participant. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:12 UTC |
Axel RobertSVP and Controller
|
GrantDeferred Compensation Shares · Derivative | 17 | $99.75 Strike: $0.00 | $1,695.75 |
DisclosureSEC source: 0001127602-22-027826 · form4.xml · derivative · entry 1 Axel Robert · CIK 0001602678 · SVP and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,503 Underlying: Common Stock · 17 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Compensation Shares are based on unitized accounting and convert to common stock on a 1 to 1 basis. F2 · derivative.exercise_date: Deferred Compensation Shares are deemed immediately exercisable and are payable in cash at a date selected by the participant. F2 · derivative.expiration_date: Deferred Compensation Shares are deemed immediately exercisable and are payable in cash at a date selected by the participant. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 20:55 UTC |
POON CHRISTINE ADirector
|
Grant2022 Restricted Stock Units · Derivative | 17 | $99.75 | $1,695.75 |
DisclosureSEC source: 0001127602-22-027807 · form4.xml · derivative · entry 3 POON CHRISTINE A · CIK 0001189014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,494 Underlying: Common Stock · 17 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive the economic equivalent of one share of PRU common stock. F6 · derivative.exercise_date: The restricted stock units vest the earlier of the annual meeting or in one year on May 10, 2023. F6 · derivative.expiration_date: The restricted stock units vest the earlier of the annual meeting or in one year on May 10, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.